Molnupiravir (Indonesian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Molnupiravir" in Indonesian language version.
refsWebsite
Global rank
Indonesian rank
1st place
1st place
doi.org
- Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, et al. (October 2019). "Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia". Science Translational Medicine. 11 (515): eaax5866. doi:10.1126/scitranslmed.aax5866. PMC 6848974
. PMID 31645453. - Toots M, Yoon JJ, Hart M, Natchus MG, Painter GR, Plemper RK (April 2020). "Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model". Translational Research. 218: 16–28. doi:10.1016/j.trsl.2019.12.002. PMC 7568909 . PMID 31945316.
fda.gov
- Commissioner, Office of the (2021-12-23). "Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults". FDA (dalam bahasa Inggris). Diakses tanggal 2022-01-14.
go.com
abcnews.go.com
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
gov.uk
- "Summary of Product Characteristics for Lagevrio". GOV.UK (dalam bahasa Inggris). Diakses tanggal 2022-01-14.
gsu.edu
news.gsu.edu
- Emerson L. "Oral Drug Tested at Georgia State Recommended for Emergency Use Authorization to Treat COVID-19 Oral Drug Tested at Georgia State Recommended for Emergency Use Authorization to Treat COVID-19". Institute for Biomedical Sciences Georgia State University. Diakses tanggal 3 October 2021.
nih.gov
ncbi.nlm.nih.gov
- Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, et al. (October 2019). "Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia". Science Translational Medicine. 11 (515): eaax5866. doi:10.1126/scitranslmed.aax5866. PMC 6848974 . PMID 31645453.
- Toots M, Yoon JJ, Hart M, Natchus MG, Painter GR, Plemper RK (April 2020). "Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model". Translational Research. 218: 16–28. doi:10.1016/j.trsl.2019.12.002. PMC 7568909 . PMID 31945316.
web.archive.org
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
- Aleccia J (29 September 2021). "Daily pill to treat COVID could be just months away". ABC News. Kaiser Health News. Diarsipkan dari versi asli tanggal 29 September 2021. Diakses tanggal 29 September 2021.
- "Wayback Machine". web.archive.org. 2021-12-24. Archived from the original on 2021-12-24. Diakses tanggal 2022-01-14.